Hybrid Surgery for Severe Mitral Valve Calcification: Limitations and Caveats for an Open Transcatheter Approach

Erik Bagaev1,2, Ahmad Ali1, Shekhar Saha1

  • 1German Centre for Cardiovascular Research (DZHK), Department of Cardiac Surgery, Ludwig Maximilian University of Munich, Partner Site Munich Heart Alliance, 80539 Munich, Germany.

Insights

This study presents a hybrid approach for high-risk patients with severe mitral stenosis and extensive mitral annular calcification (MAC). The novel technique shows promising results for reducing surgical risks and improving outcomes in complex cases.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Biomaterials in Medicine

Background:

  • Severe mitral stenosis with extensive mitral annular calcification (MAC) presents significant surgical challenges.
  • Traditional surgical approaches carry risks such as prolonged surgery, ventricular rupture, and systolic anterior motion.
  • Existing treatments often have limitations for patients with severe MAC.

Purpose of the Study:

  • To evaluate a novel hybrid approach for mitral valve replacement in patients with severe mitral stenosis and extensive MAC.
  • To reduce the risks of ventricular rupture, paravalvular leaks, and outflow tract obstruction.
  • To assess the feasibility and early outcomes of this alternative surgical strategy.

Main Methods:

  • A hybrid approach involving open implantation of an Edwards Sapien 3 prosthesis was performed on cardiopulmonary bypass in six female patients (mean age 76 ± 9 years).
  • The technique included resection of the anterior mitral leaflet, placement of anchor sutures, and visual deployment of a balloon-expandable prosthesis.
  • Concomitant procedures were performed in three patients.

Main Results:

  • Mean cross-clamp time was 95 ± 31 min and cardiopulmonary bypass time was 137 ± 60 min.
  • Perioperative TEE revealed typical gradients and clinically irrelevant paravalvular leakage in the anterior annulus in three patients.
  • Mild to moderate gradients were noted in the left ventricular outflow tract; no cerebrovascular events or pacemaker implantations occurred. Survival to discharge was 83.3% at one year.

Conclusions:

  • The "off-label" implantation of the Edwards Sapien 3 prosthesis using this hybrid approach is a viable bail-out option.
  • This method is suitable for high-risk patients or those deemed inoperable due to extensive MAC.
  • The approach may mitigate risks associated with conventional mitral valve surgery in complex cases.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
36
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
46
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
72
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
56